Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.00 is 100% above its 1-year average of -0.05, near the high end of its 1-year range (-0.26–0.00).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% above its 12-month average of -0.05.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00.
DEBT TO EQUITY RATIO
0.00
DEBT TO EQUITY RATIO AVG TTM
-0.05
DEBT TO EQUITY RATIO AVG 3Y
0.00
DEBT TO EQUITY RATIO AVG 5Y
0.00
DEBT TO EQUITY RATIO AVG 10Y
0.00
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 746 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Minerva Neurosciences, Inc.
Market Cap
$159.57M
Debt to Equity Ratio
0.00
TTM Avg
-0.05
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$158.36M
Debt to Equity Ratio
0.62
TTM Avg
0.66
3Y Avg
0.66
5Y Avg
2.14
Market Cap
$155.82M
Debt to Equity Ratio
4.85
TTM Avg
3.51
3Y Avg
2.39
5Y Avg
1.92
Market Cap
$154.72M
Debt to Equity Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$163.22M
Debt to Equity Ratio
0.14
TTM Avg
0.12
3Y Avg
0.12
5Y Avg
0.11
Market Cap
$165.70M
Debt to Equity Ratio
0.15
TTM Avg
0.24
3Y Avg
0.19
5Y Avg
0.13
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | $159.57M | 0.00 | -0.05 | 0.00 | 0.00 |
| Coherus Oncology, Inc. (CHRS)vs › | $158.36M | 0.62 | 0.66 | 0.66 | 2.14 |
| PepGen Inc. (PEPG)vs › | $158.74M | 0.13 | 0.14 | 0.15 | 0.10 |
| Inogen, Inc. (INGN)vs › | $157.47M | 0.09 | 0.10 | 0.10 | 0.08 |
| Neuronetics, Inc. (STIM)vs › | $155.82M | 4.85 | 3.51 | 2.39 | 1.92 |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $154.72M | N/A | N/A | N/A | N/A |
| Quanterix Corporation (QTRX)vs › | $163.22M | 0.14 | 0.12 | 0.12 | 0.11 |
| OptimizeRx Corp. (OPRX)vs › | $165.70M | 0.15 | 0.24 | 0.19 | 0.13 |
| LifeMD, Inc. (LFMDP)vs › | $154.79M | 0.76 | 0.27 | 2.83 | 1.63 |
| Nkarta, Inc. (NKTX)vs › | $167.77M | 0.30 | 0.22 | 0.24 | 0.18 |
Debt/Equity
0.00
Current Ratio
20.14
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.00 |
| 2026-03-31 | -0.26 |
| 2025-12-31 | 0.00 |
| 2025-09-30 | 0.00 |
| 2025-06-30 | 0.00 |
| 2025-03-31 | 0.00 |
| 2024-12-31 | 0.00 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | -1.95 |
| 2024-03-31 | -2.30 |
| 2023-12-31 | 0.00 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.00 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | -8.34 |
| 2022-03-31 | -92.52 |
| 2021-12-31 | 0.00 |
| 2021-09-30 | 0.00 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.00 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.01 |
| 2019-12-31 | 0.01 |
| 2019-09-30 | 0.01 |
| 2019-06-30 | 0.01 |
| 2019-03-31 | 0.01 |
| 2018-12-31 | 0.00 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.01 |
| 2018-03-31 | 0.02 |
| 2017-12-31 | 0.03 |
| 2017-09-30 | 0.04 |
| 2017-06-30 | 0.07 |
| 2017-03-31 | 0.07 |
| 2016-12-31 | 0.08 |
| 2016-09-30 | 0.09 |
| 2016-06-30 | 0.08 |
| 2016-03-31 | 0.15 |
| 2015-12-31 | 0.18 |
| 2015-09-30 | 0.16 |
| 2015-06-30 | 0.14 |
| 2015-03-31 | 0.13 |
| 2014-12-31 | 0.00 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.12 |
| 2014-03-31 | 0.02 |
| 2013-12-31 | 0.00 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
